Prem Rugby extends deal with trading platform Etoro September 30, 2026 Trading platform Etoro has extended its partnership with Prem Rugby as it solidifies its growing status within sport. The agreement began in 2023 but a fresh extension will see the deal extend into a fourth season, with the firm sponsoring the league’s predictor activation across social media. It is also the league’s official coin-toss partner [...]
Amentum Joint Venture Secures Preferred Position for Major UK Nuclear Contract September 30, 2026 United Kingdom nuclear site operator Sellafield Ltd has selected an Amentum (NYSE: AMTM) joint venture as preferred supplier for an asset care and asset creation program valued at up to $2.78 billion (£2.1 billion). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260930996796/en/ Under the Projects and Asset Care Execution (PACE) framework contract, [...]
Greggs puts 740 jobs at risk as baker braces for worse inflation September 30, 2026 Greggs has announced a shakeup of its manufacturing processes which could lead to the closure of four factories and cost 740 jobs, as the baker warns of “greater inflationary pressures” across its business. The sausage roll seller told shareholders on Wednesday that it is consulting on a move to consolidate its manufacturing operations, which would [...]
UK disposable income rises as benefits payouts soar ahead of wages September 30, 2026 The average UK household’s disposable income increased in the second quarter of the year driven by a rise in benefit payouts. Real household disposable income per head – which measures the average spending and saving capacity of Brits – increased by one per cent in the second quarter to £6,577, new figures from the Office [...]
rhode Launches at Sephora in Europe, Marking Its First Retail Presence Across 19 New Markets September 30, 2026 The launch brings rhode into physical retail across Europe, previously only being available for purchase in the region through rhodeskin.com
As it happened: FTSE 100 gives up gains as oil rises despite emergency release; UK GDP revised September 30, 2026 Welcome back to the City AM liveblog. Stick with us throughout the day for the latest London Stock Exchange and wider business and economic news, as soon as we get it. Here’s a look at some of our top headlines: The liveblog has ended.No liveblog updates yet. Load more
The sugar rush is over: The Big Four must wake up from their pandemic dream September 30, 2026 The pandemic was the worst thing that could have happened to the Big Four giants and the overall consultancy market. At the time, these firms were flying high, flooded with inquiries from businesses needing help to navigate the ‘once-in-a-lifetime ‘ event, but this ‘sugar rush’ didn’t last forever, and it gave the industry a false [...]
Exclusive: Mayors can use tourist tax to ramp up borrowing, Burnham tells business September 30, 2026 Andy Burnham has looked to justify his new uncapped “tourist tax” to business chiefs by claiming it will allow mayors to ramp up borrowing, City AM understands. In various meetings at Labour’s Business Day, top business groups were told by ministers the so-called overnight stay levy will let mayors take on more debt and use [...]
Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026 September 30, 2026 Almirall’s scientific programme at EADV 2026 showcases advances in critical skin diseases, including atopic dermatitis, psoriasis and actinic keratosis, through more than 20 abstracts, including a late-breaking abstracts, alongside two expert-led symposia and an interactive industry AD hub session. New clinical data show consistent efficacy and effectiveness in atopic dermatitis treatment across body regions with lebrikizumab, including high-impact areas such as the face and neck1,2, while late-breaking ADlong results highlight sustained improvements in skin signs and itch with up to five years of treatment3. Final two-year data from the POSITIVE clinical study demonstrate the benefits on patient overall well-being and quality of life during tildrakizumab treatment4,5, and further data show evidence in patients with high disease burden and previous biologic treatment6,7. Almirall’s commitment to medical dermatology is reflected by its Gold Sponsorship of EADV 2026 and the launch of the ‘Face It’-campaign to raise awareness of the burden of atopic dermatitis with face and neck involvement, addressing the broader impact of skin diseases on patients.
James Reed: Celebrating wealth could energise young people September 30, 2026 Fostering a more supportive and celebratory culture around wealth creation could help inspire more young people, writes James Reed.